Boiron SA (LON: 0DTF)
London
· Delayed Price · Currency is GBP · Price in EUR
27.60
+1.45 (5.54%)
Jan 22, 2025, 1:15 PM BST
Boiron Revenue
Boiron had revenue of 228.35M EUR in the half year ending June 30, 2024, a decrease of -11.07%. This brings the company's revenue in the last twelve months to 481.71M, down -6.89% year-over-year. In the year 2023, Boiron had annual revenue of 493.25M, down -7.67%.
Revenue (ttm)
481.71M EUR
Revenue Growth
-6.89%
P/S Ratio
n/a
Revenue / Employee
171.43K EUR
Employees
2,810
Market Cap
400.85M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 493.25M | -40.99M | -7.67% |
Dec 31, 2022 | 534.24M | 79.04M | 17.36% |
Dec 31, 2021 | 455.20M | -58.38M | -11.37% |
Dec 31, 2020 | 513.58M | -43.54M | -7.82% |
Dec 31, 2019 | 557.13M | -47.09M | -7.79% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |